ideal
anim
model
studi
human
diseas
one
util
rout
infect
mimic
natur
transmiss
pathogen
abil
obtain
diseas
infecti
dose
equival
caus
diseas
human
well
diseas
cours
morbid
mortal
similar
seen
human
diseas
addit
anim
model
mode
transmiss
mimic
human
case
factor
subsequ
allow
detail
infer
diseas
pathogenesi
includ
avail
reagent
evalu
host
innat
adapt
immun
respons
pathogen
histopatholog
chang
host
result
infect
host
respons
infect
find
compar
known
human
diseas
util
small
anim
model
human
diseas
studi
therapeut
efficaci
augment
larg
number
anim
avail
use
appropri
wellpow
studi
even
aspect
anim
model
diseas
complet
faith
known
human
diseas
import
inform
regard
therapeut
efficaci
glean
use
preclin
studi
publish
literatur
clinic
manifest
system
human
orthopoxviru
diseas
deriv
histor
literatur
descript
human
smallpox
recent
descript
human
monkeypox
diseas
clinicaldescript
literatur
human
monkeypox
expect
grow
next
five
year
data
acquisit
analysi
ongo
studi
democrat
republ
congo
final
current
avail
literatur
larg
deriv
whosponsor
surveil
effort
west
africa
congo
basin
first
recognit
human
diseas
area
subsequ
analys
public
health
respons
data
human
research
studi
follow
introduct
west
african
clade
viru
us
human
monkeypox
describ
activ
surveil
case
ascertain
studi
sponsor
depict
resembl
discret
ordinari
smallpox
natur
human
infect
exposur
lead
infect
believ
occur
via
respiratori
rout
subsequ
progress
viremiaslymphemia
ultim
lead
seed
skin
gener
gener
rash
percutan
exposur
also
lead
gener
rash
format
also
describ
viral
infect
diseas
pathogenesi
conjectur
model
larg
anim
studi
initi
model
use
ectromelia
infect
mice
kinet
observ
viru
shed
viremia
made
human
studi
smallpox
monkeypox
time
cours
diseas
gener
thought
includ
asymptomat
phase
day
time
viru
initi
enter
host
replic
seed
reticuloendotheli
organ
replic
spread
via
bloodstream
induc
febril
respons
first
symptomat
hallmark
diseas
fever
usual
describ
occur
day
post
initi
exposureinfect
rang
day
fever
accompani
symptom
includ
headach
backach
myalgia
abdomin
pain
two
three
day
follow
fever
rash
present
macular
papular
vesicular
pustular
erupt
scab
begin
stage
rash
last
day
approxim
week
post
initi
symptom
scab
begin
separ
skin
death
diseas
sever
correl
rash
burden
epidemiolog
studi
hospit
smallpox
patient
sever
outcom
frequent
unvaccin
younger
age
group
death
occur
within
first
week
ill
case
hemorrhag
manifest
second
third
week
ill
ordinari
case
human
monkeypox
case
studi
zairedrc
death
among
patient
occur
unvaccin
children
less
eight
year
age
death
occur
first
week
ill
second
week
third
week
ill
remain
develop
small
anim
model
studi
monkeypox
viru
mpxv
quit
extens
rel
short
period
time
pathogen
known
initi
anim
model
design
address
natur
histori
potenti
surrog
reservoir
host
speci
well
studi
diseas
primat
rout
exposur
design
evalu
diseas
respiratori
percutan
exposur
occur
case
simpli
address
whether
viru
would
replic
anim
model
system
factor
influenc
outcom
challeng
studi
includ
age
anim
time
infect
inocul
rout
use
viral
dosag
given
addit
strain
mpxv
current
delin
belong
congo
basin
clade
west
african
clade
use
studi
may
influenc
diseas
sever
guinea
pig
golden
hamster
found
rel
resist
mpxv
west
african
clade
copenhagen
strain
infect
multipl
rout
guinea
pig
challeng
via
intracardi
intranas
oral
foot
pad
fp
inocul
observ
symptom
diseas
except
edema
fp
inocul
site
golden
hamster
also
resist
mpxv
infect
via
sever
rout
infect
observ
sign
diseas
even
larg
dosag
viru
rabbit
also
consid
possibl
anim
model
studi
mpxv
suscept
depend
greatli
method
inocul
age
anim
adult
rabbit
challeng
mpxv
west
african
clade
copenhagen
strain
via
oral
inocul
sign
diseas
seen
howev
viru
deliv
intraven
rout
acut
ill
observ
gener
rash
young
rabbit
day
old
inocul
via
oral
rout
develop
sever
ill
two
day
old
rabbit
highli
suscept
infect
intracutan
inocul
skin
scarif
intracutan
rout
led
develop
discret
white
transluc
lesion
anoth
studi
found
intracerebr
inocul
fatal
intratesticular
intracorn
inocul
mpxv
also
pathogen
rabbit
sever
rat
speci
includ
white
rat
cotton
rat
multimamm
rat
challeng
mpxv
adult
white
rat
inocul
plaqu
form
unit
pfu
west
african
mpxv
suscept
infect
intraven
cutan
rout
infect
howev
newborn
white
rat
day
old
develop
adynamia
lead
death
day
challeng
mpxv
intranas
cotton
rat
multimamm
rat
found
highli
suscept
mpxv
infect
cotton
rat
challeng
pfu
via
intraven
rout
infect
mortal
seen
day
post
infect
pi
infect
character
difficulti
breath
cough
sneez
cyanosi
rhiniti
purul
conjunct
progress
emaci
mpxv
challeng
cotton
rat
caus
mortal
clinic
pictur
seen
intraven
rout
multimamm
rat
highli
sensit
intraperiton
ip
inocul
marennikova
et
al
challeng
adult
common
squirrel
sciuru
vulgari
pfu
mpxv
congo
basin
clade
via
oral
scarif
rout
infect
diseas
progress
occur
earlier
anim
infect
oral
anim
infect
via
scarif
rout
skin
lesion
develop
anim
symptom
diseas
includ
fever
inact
inappet
rhiniti
cough
difficulti
breath
infect
lethal
day
pi
regardless
inocul
rout
shelukhina
et
al
challeng
six
african
squirrel
speci
includ
member
genera
funisciuru
protexeru
heliosciuru
congo
basin
mpxv
via
infect
ml
squirrel
speci
highli
suscept
congo
basin
mpxv
challeng
develop
acut
gener
infect
lethal
howev
vari
degre
suscept
differ
squirrel
speci
seen
lesser
dosag
viru
cutan
inocul
squirrel
result
thick
red
papul
inocul
site
skin
lesion
restrict
nonfurbear
area
skin
border
skin
mucou
membran
nose
lip
occur
squirrel
infect
oral
rout
small
nonleth
dose
viru
often
rash
appear
later
stage
diseas
day
pi
transmiss
studi
also
conduct
squirrel
author
found
infect
anim
abl
transmit
diseas
anim
via
airborn
direct
contact
ground
squirrel
spermophilu
tridecemlineatu
suscept
mpxv
infect
tesh
et
al
challeng
adult
ground
squirrel
west
african
mpxv
clade
either
ip
pfu
group
symptom
diseas
includ
anorexia
lethargi
within
day
infect
observ
symptom
weight
loss
measur
anim
anim
ip
group
die
within
day
pi
challeng
die
within
day
followup
studi
compar
pathogenesi
two
mpvx
clade
ground
squirrel
model
inocul
pfu
subcutan
rout
infect
lethal
mpxv
clade
howev
author
note
onset
sever
respiratori
distress
rapid
uniform
congo
basin
mpxv
challeng
anim
addit
anim
challeng
congo
basin
mpxv
began
die
earlier
west
african
challeng
anim
howev
valu
similar
two
strain
use
ground
squirrel
mpxv
model
pfu
congo
basin
pfu
west
african
mpxv
prairi
dog
also
look
possibl
mpxv
anim
model
xiao
et
al
challeng
prairi
dog
pfu
west
african
mpxv
via
ip
rout
infect
observ
mortal
respect
hutson
et
al
challeng
prairi
dog
either
congo
basin
west
african
mpxv
pfu
via
scarif
rout
infect
anim
asymptomat
day
gener
rash
observ
challeng
anim
sign
diseas
includ
lethargi
inappet
nasal
discharg
respiratori
distress
diarrhea
morbid
notic
congo
basin
mpxv
challeng
anim
mortal
followup
studi
found
prairi
dog
mpxv
model
approxim
hundredtim
lower
congo
basin
clade
compar
west
african
clade
respect
util
rout
infect
weight
loss
occur
west
african
mpxv
challeng
dosag
group
congo
basin
mpxv
challeng
dosag
group
viral
strain
highest
percent
weight
loss
calcul
occur
highest
viral
inoculum
group
trend
increas
viral
titer
oropharyng
swab
increas
viral
inoculum
dose
appar
mpxv
strain
mean
valu
combin
congo
basin
challeng
anim
statist
higher
level
viru
furthermor
durat
mpxv
dna
viral
shed
tend
occur
earlier
attain
higher
level
persist
longer
congo
basin
challeng
anim
symptom
also
numer
sever
congo
basin
mpxv
infect
prairi
dog
schultz
et
al
challeng
african
dormic
graphiuri
kelleni
pfu
congo
basin
clade
mpxv
via
fp
rout
observ
mortal
author
develop
model
infect
dormic
variou
dosag
congo
basin
mpxv
rout
calcul
pfu
anim
becam
symptomat
day
conjunct
dehydr
anim
succumb
diseas
mean
time
death
day
depend
dose
morbid
anim
succumb
diseas
includ
decreas
activ
hunch
postur
unkempt
hair
coat
dehydr
conjunct
lesion
develop
anim
weight
loss
highest
pfu
highest
dosag
given
also
seen
anim
given
pfu
weight
loss
observ
lowest
dosag
group
pfu
diseas
pathogenesi
describ
local
inflamm
viral
replic
hemorrhag
nasal
mucosa
follow
dissemin
around
day
subsequ
necrosi
liver
spleen
lung
gastrointestin
tract
tissu
west
african
strain
mpxv
use
challeng
dormic
infect
similar
day
death
mortal
rate
seen
congo
basin
mpxv
challeng
anim
case
mani
pathogen
mice
util
numer
time
studi
mpxv
result
vari
greatli
depend
type
mice
use
ie
wild
strain
laboratori
strain
earli
studi
white
mice
challeng
via
intracerebr
ip
fp
oral
intraderm
id
inocul
west
african
strain
mpxv
found
highli
sensit
inocul
rout
intracerebr
inocul
fatal
adult
white
mice
inocul
suckl
mice
inocul
eight
day
old
mice
via
fp
ip
rout
result
mortal
id
oral
inocul
caus
mortal
respect
oral
inocul
day
old
white
mice
caus
mortal
howev
inocul
day
old
anim
led
mortal
inbr
laboratori
mous
strain
also
studi
sever
group
hutson
et
al
compar
two
clade
viru
pfu
immunocompet
balbc
laboratori
mous
strain
via
fp
rout
infect
local
sign
fp
challeng
anim
includ
edema
inocul
site
congo
basin
rout
infect
led
weight
loss
howev
symptom
minim
anim
surviv
infect
osorio
et
al
compar
clade
viru
ip
inocul
either
balbc
sever
combin
immun
defici
scid
balbc
mice
biophoton
imag
use
visual
diseas
progress
balbc
mice
develop
rough
coat
decreas
activ
clear
infect
within
day
pi
contrast
scid
balbc
mice
develop
similar
symptom
result
mortal
day
pi
congo
basin
mpxv
day
pi
west
african
mpxv
stabenow
et
al
util
laboratori
mous
strain
lack
import
protein
involv
type
type
ii
ifn
signal
mice
challeng
dosag
pfu
via
rout
infect
weight
loss
seen
dosag
given
except
lowest
pfu
mortal
occur
pfu
dose
day
pi
mortal
occur
day
pi
highest
dose
given
pfu
calcul
congo
basin
clade
mice
pfu
femal
male
respect
americo
et
al
screen
inbr
mous
strain
identifi
three
highli
suscept
mpxv
three
strain
casteij
develop
model
sign
morbid
moribund
anim
includ
ruffl
fur
hunch
postur
lethargi
anim
develop
lesion
anim
challeng
highest
dosag
rout
pfu
congo
basin
mpxv
lost
start
bodi
weight
die
day
anim
challeng
pfu
die
day
anim
challeng
pfu
even
longer
delay
weight
loss
death
anim
recov
anim
perish
pfu
challeng
group
calcul
congo
basin
clade
casteij
mice
given
challeng
pfu
anim
found
even
sensit
ip
congo
basin
mpxv
infect
calcul
pfu
challeng
mice
pfu
west
african
mpxv
strain
result
rapid
weight
loss
mortal
day
pi
lower
dosag
west
african
mpxv
result
less
weight
loss
lower
amount
death
observ
congo
basin
mpxv
calcul
pfu
log
higher
congo
basin
clade
date
four
mpxv
small
anim
model
use
test
antivir
drug
cidofovir
tecovirimat
herein
summar
studi
efficaci
data
discuss
advantag
limit
anim
model
use
sbrana
et
al
util
ground
squirrel
test
efficaci
mpxv
challeng
author
use
pfu
via
subcutan
rout
inocul
squirrel
per
group
divid
five
treatment
group
drug
given
either
hour
infect
hour
hour
hour
hour
pi
mgkg
drug
given
day
day
two
anim
group
sacrif
day
measur
object
morbid
remaind
anim
use
calcul
surviv
rate
anim
placebo
group
given
show
sign
ill
begin
day
die
day
sign
diseas
includ
lethargi
anorexia
noseble
termin
respiratori
distress
day
sampl
placebotr
anim
exhibit
signific
leukocytosi
transamin
coagulopathi
almost
pfuml
infecti
monkeypox
found
blood
time
pfu
ml
infecti
mpxv
observ
organ
homogen
liver
spleen
lung
anim
treat
day
hour
symptomat
diseas
onset
surviv
infect
show
sign
diseas
day
sampl
anim
treat
hour
pi
viru
found
liver
spleen
lung
blood
although
abnorm
valu
appar
record
clear
trend
leukocytosi
transamin
coagulopathi
note
delay
treatment
onset
anim
initi
treatment
hour
pi
concurr
symptomat
diseas
onset
anim
surviv
infect
survivor
show
sign
diseas
anim
succumb
infect
prolong
time
death
mean
time
death
day
anim
receiv
placebo
day
receiv
hour
pi
treatment
group
sampl
anim
day
initi
hour
pi
demonstr
lower
level
viremia
log
decreas
log
less
viru
liver
spleen
lung
seen
placebo
treat
anim
day
although
evid
transamin
present
leukocytosi
coagulopathi
observ
treatment
group
patholog
examin
tissu
gener
show
greater
tissu
necrosi
anim
treat
later
time
pi
studi
abl
demonstr
surviv
benefit
anim
treat
prior
onset
diseas
symptom
diseas
model
time
cours
attenu
respect
seen
human
diseas
schultz
et
al
infect
african
dormic
lethal
challeng
congo
basin
clade
viru
via
rout
infect
evalu
efficaci
cidofovir
post
exposur
prophylaxi
four
hour
post
intranas
infect
pfu
mpxv
anim
intraperiton
administ
mgkg
cidofovir
calcul
dormous
mpxv
model
pfu
aggreg
data
challeng
show
anim
treat
cidofovir
mortal
rate
wherea
vehicl
treat
anim
succumb
diseas
treatment
initi
later
time
pi
evalu
effect
viral
load
histopatholog
chang
report
inbr
mice
histor
shown
littl
diseas
symptomatolog
pathogenesi
post
monkeypox
infect
stabenow
et
al
util
laboratori
mous
strain
lack
found
sensit
rang
virus
includ
sar
murin
noroviru
respiratori
virus
dengu
viru
mpxv
anim
defici
abil
transcrib
mani
type
type
ii
receptor
interferon
respons
gene
author
use
congo
basin
clade
viru
evalu
diseas
protect
efficaci
untreat
mice
mortal
observ
pfu
challeng
mortal
pfu
viru
mortal
pfu
total
bodi
weight
loss
mortal
observ
prior
day
pi
untreat
anim
anim
treatment
studi
subsequ
challeng
pfu
via
infect
anim
treat
mgkg
gastric
gavag
day
challeng
follow
everi
day
mgkg
day
pi
stat
mice
treat
drug
surviv
infect
demonstr
bodi
weight
loss
day
develop
serolog
respons
monkeypox
similarli
mice
treat
daili
start
day
viru
challeng
day
also
surviv
infect
manifest
bodi
weight
loss
day
system
antivir
treat
anim
rechalleng
monkeypox
day
post
initi
infect
least
day
post
reiniti
steadi
weight
gain
manifest
mortal
one
short
diseas
use
demonstr
immedi
post
exposur
efficaci
antivir
treatment
absenc
function
interferon
respons
system
addit
anim
model
system
perhap
due
immun
defect
monkeypox
protect
immun
respons
elicit
anim
receiv
antivir
treatment
observ
merit
observ
anim
model
system
smith
et
al
test
efficaci
prairi
dog
mpxv
model
mpxv
challeng
prairi
dog
previous
shown
asymptomat
period
follow
symptom
diseas
includ
lethargi
nasal
discharg
inappet
weight
loss
system
lesion
develop
commonli
day
current
studi
anim
inocul
via
challeng
congo
basin
clade
viru
differ
strain
mpxv
use
previou
describ
studi
also
strain
belong
congo
basin
clade
challeng
dose
equal
prairi
dog
model
anim
divid
three
treatment
group
prophylact
day
post
exposur
day
therapeut
vari
day
base
rash
onset
control
vehicl
treat
group
formul
mgml
administ
daili
oral
gavag
day
anim
initi
treatment
day
protect
death
appar
sign
ill
anim
treat
rash
onset
symptom
similar
placebo
control
group
howev
symptom
less
sever
treat
anim
although
anim
treat
rash
onset
surviv
infect
anim
lost
bodi
weight
develop
gener
rash
howev
lesion
resolv
quickli
compar
untreat
prairi
dog
previou
studi
although
asymptomat
viabl
viru
shed
sporad
anim
prophylaxi
post
exposur
group
two
oropharyng
sampl
day
prophylaxi
group
five
sampl
day
post
exposur
group
sustain
viru
detect
oropharyng
sampl
anim
therapeut
treatment
group
level
less
viru
level
untreat
group
shamtreat
anim
surviv
infect
sign
diseas
viral
titer
increas
group
anim
compar
anim
treat
first
small
anim
studi
treatment
surviv
benefit
demonstr
anim
treat
later
stage
ill
initi
treatment
rash
onset
similar
expect
human
treatment
regimen
observ
viru
shed
treatment
cessat
prophylact
post
exposur
treat
anim
merit
studi
assess
whether
reflect
viral
resist
blunt
delay
immun
recognit
ultim
clearanc
viru
anim
model
permit
advanc
beyond
glean
tissu
cultur
evalu
antivir
effect
evalu
antivir
context
host
function
immun
system
enabl
better
understand
therapeut
potenti
efficaci
evalu
antivir
context
impair
immun
system
enabl
better
understand
therapeut
use
particular
immunosuppress
popul
pathogen
host
rang
especi
simpl
issu
receptor
util
confound
abil
interpret
extrapol
human
nuanc
host
pathogen
interact
predict
potenti
human
therapeut
benefit
small
anim
model
use
evalu
antivir
efficaci
use
stringent
viru
challeng
greater
shown
surviv
benefit
rout
infect
use
method
attempt
simul
potenti
human
rout
infect
result
human
ill
cours
given
uncertainti
human
infecti
lethal
monkeypox
dose
difficult
extrapol
potenti
best
fit
model
human
diseas
clinic
time
cours
diseas
prairi
dog
model
howev
tempor
relationship
close
describ
human
system
orthopoxviru
variola
monkeypox
diseas
howev
limit
prairi
dog
describ
anim
system
except
mous
model
pauciti
immun
reagent
hand
antivir
compound
show
promis
small
anim
model
use
monkeypox
viru
challeng
addit
studi
evalu
treatment
benefit
use
later
stage
diseas
effect
elicit
protect
immun
respons
evalu
antivir
resist
effect
viral
shed
improv
understand
may
use
treatment
human
diseas
respons
epidem
diseas
